MedPath

BOSTON SCIENTIFIC CORPORATION

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein

Phase 3
Terminated
Conditions
Hepatocellular Carcinoma
Interventions
Device: TheraSphere®
Drug: Sorafenib
First Posted Date
2013-06-27
Last Posted Date
2021-04-21
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
36
Registration Number
NCT01887717
Locations
🇺🇸

Northwestern Medical Faculty Foundation, Div of Hematology/Oncology, Chicago, Illinois, United States

🇫🇷

Paoli-Calmettes Institute, Marseille, France

🇧🇪

Cliniques Universitaires Saint-Luc, Brussels, Belgium

and more 16 locations

MADIT ASIA Cardiac Resynchronization Trial

Phase 3
Terminated
Conditions
Congestive Heart Failure
Left Bundle Branch Block
Heart Failure, Systolic
Interventions
Device: Two-lead CRT-P
First Posted Date
2013-06-07
Last Posted Date
2014-04-30
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
1
Registration Number
NCT01872234
Locations
🇸🇬

National Heart Center, Singapore, Singapore

🇮🇳

Medanta-Medicity, Gurgaon, Haryana, India

🇮🇳

CARE Hospital Nampally, Hyderabad, Hyderabad, India

and more 18 locations

Safety and Performance Study of the RELIANCE 4-Front Passive Fixation Lead

Not Applicable
Completed
Conditions
Ventricular Fibrillation
Tachycardia
Ventricular Flutter
Interventions
Device: RELIANCE 4-FRONT™ Passive Fixation lead implantation
First Posted Date
2013-05-17
Last Posted Date
2019-04-30
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
167
Registration Number
NCT01856491
Locations
🇩🇪

German Heart Center, Berlin, Germany

🇮🇱

Meir Medical Center, Kfar-Saba, Israel

🇮🇱

Beilinson Medical Center, Petah-Tikva, Israel

and more 8 locations

Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease

Not Applicable
Completed
Conditions
Parkinson's Disease
Interventions
Device: Deep Brain Stimulation
First Posted Date
2013-04-24
Last Posted Date
2023-07-13
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
313
Registration Number
NCT01839396
Locations
🇺🇸

Carepoint, PC d/b/a Blue Sky Neurology, Englewood, Colorado, United States

🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

🇺🇸

University of Florida Shands Hospital, Gainesville, Florida, United States

and more 19 locations

Stenting of the Superficial Femoral and/or Proximal Popliteal Artery Project

Not Applicable
Completed
Conditions
Atherosclerosis of Native Arteries of the Extremities
Interventions
Device: The Boston Scientific DES SFA Paclitaxel-Eluting Self-Expanding Stent System (DES SFA)
First Posted Date
2013-03-29
Last Posted Date
2019-03-22
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
57
Registration Number
NCT01820637
Locations
🇦🇺

Prince of Wales Hospital, Randwick, Australia

🇦🇺

Royal Prince Alfred Hospital, Camperdown, Australia

🇦🇹

Allgemeines Krankenhaus AKH, Vienna, Austria, Austria

and more 10 locations

Post Market Observational, Prospective, Multi-center Study

Terminated
Conditions
Emphysema
Interventions
Device: PneumRx Coil System
First Posted Date
2013-03-07
Last Posted Date
2021-07-16
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
1275
Registration Number
NCT01806636
Locations
🇩🇪

Brüderkrankenhaus St. Josef Paderborn, Paderborn, Germany

🇩🇪

Universitätsklinikum, Regensburg, Germany

🇩🇪

RoMed Klinikum Rosenheim, Rosenheim, Germany

and more 70 locations

Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma

Not Applicable
Completed
Conditions
Hepatocellular Carcinoma
Interventions
Device: TANDEM™
First Posted Date
2013-02-25
Last Posted Date
2016-10-03
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
25
Registration Number
NCT01798134
Locations
🇩🇪

Kilinikum Darmstadt, Darmstadt, Hessen, Germany

🇩🇪

Universitatsklinikum Essen, Essen, Nordrhein-Westfalen, Germany

🇩🇪

University Hospital Regensburg, Regensburg, Germany

and more 4 locations

EVOLVE II QCA: A Prospective, Multicenter Trial to Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Phase 3
Completed
Conditions
Atherosclerotic Lesion(s)
Interventions
Device: SYNERGY
First Posted Date
2013-02-11
Last Posted Date
2016-03-16
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
100
Registration Number
NCT01787799
Locations
🇦🇺

The Prince Charles Hospital, Chermside, Queensland, Australia

🇦🇺

St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia

🇦🇺

Fremantle Hospital, Fremantle, Western Australia, Australia

and more 10 locations

Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence

Not Applicable
Completed
Conditions
Stress Urinary Incontinence
Interventions
Device: Solyx Single Incision Sling System
Device: Obtryx II Sling System
First Posted Date
2013-02-06
Last Posted Date
2021-02-10
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
281
Registration Number
NCT01784588
Locations
🇺🇸

Cherokee Women's Health Specialist, Canton, Georgia, United States

🇺🇸

Physicians Regional Healthcare, Naples, Florida, United States

🇺🇸

Novant Health Presbyterian Medical Center, Charlotte, North Carolina, United States

and more 20 locations

ImageReady(TM) MR Conditional Pacing System Clinical Study

Not Applicable
Completed
Conditions
Sinus Node Dysfunction
Bradycardia
Interventions
Radiation: MRI
Device: ImageReady System implant
First Posted Date
2013-01-31
Last Posted Date
2019-12-03
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
363
Registration Number
NCT01781078
Locations
🇺🇸

OhioHealth Research and Innovation Institute, Columbus, Ohio, United States

🇺🇸

United Heart and Vascular Clinic, Saint Paul, Minnesota, United States

🇺🇸

William Beaumont Hospital, Royal Oak, Michigan, United States

and more 38 locations
© Copyright 2025. All Rights Reserved by MedPath